Clearmind Medicine prices $1.75 million convertible note conversion at $0.6 a share
PUBT · 5d ago
Share
Listen to the news
- Clearmind Medicine entered securities purchase agreements on Sept. 17, 2025 to issue up to $10 million of convertible promissory notes.
- On April 14, 2026, Clearmind delivered notice to issue $1.75 million of convertible promissory notes for cash purchase price of $1.58 million.
- On April 15, 2026, CLA Investors converted $1.75 million of promissory notes at $0.60 per common share.
- Conversion agreement also reset promissory note floor price to $0.60 per common share.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Clearmind Medicine Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001213900-26-043758), on April 15, 2026, and is solely responsible for the information contained therein.
Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.
What's Trending
No content on the Webull website shall be considered a recommendation or solicitation for the purchase or sale of securities, options or other investment products. All information and data on the website is for reference only and no historical data shall be considered as the basis for judging future trends.
Copyright © 2026 Webull. All Rights Reserved